Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.3300
-0.0265 (-7.43%)
At close: May 12, 2025, 4:00 PM
0.3470
+0.0170 (5.15%)
After-hours: May 12, 2025, 7:47 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $15.35 million as of May 12, 2025. Its market cap has decreased by -83.74% in one year.
Market Cap
15.35M
Enterprise Value
16.19M
1-Year Change
-83.74%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $15.35M, a decrease of -95.61%. That is a compound annual growth rate of -63.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 16.58M | -81.43% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |